54 related articles for article (PubMed ID: 17476292)
1. Activation of the MAP kinase pathway induces apoptosis in the Merkel cell carcinoma cell line UISO.
Houben R; Ortmann S; Schrama D; Herold MJ; Berberich I; Reichardt HM; Becker JC
J Invest Dermatol; 2007 Sep; 127(9):2116-22. PubMed ID: 17476292
[TBL] [Abstract][Full Text] [Related]
2. Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma.
Houben R; Michel B; Vetter-Kauczok CS; Pföhler C; Laetsch B; Wolter MD; Leonard JH; Trefzer U; Ugurel S; Schrama D; Becker JC
J Invest Dermatol; 2006 May; 126(5):1135-42. PubMed ID: 16498399
[TBL] [Abstract][Full Text] [Related]
3. Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
Hafner C; Houben R; Baeurle A; Ritter C; Schrama D; Landthaler M; Becker JC
PLoS One; 2012; 7(2):e31255. PubMed ID: 22363598
[TBL] [Abstract][Full Text] [Related]
4. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
5. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
Anderson LR; Sutherland RL; Butt AJ
Oncogene; 2010 Jan; 29(4):527-38. PubMed ID: 19881545
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
8. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
10. RKIP does not contribute to MAP kinase pathway silencing in the Merkel Cell Carcinoma cell line UISO.
Houben R; Ortmann S; Becker JC
J Carcinog; 2007 Oct; 6():16. PubMed ID: 17958888
[TBL] [Abstract][Full Text] [Related]
11. Chronic mTOR activation promotes cell survival in Merkel cell carcinoma.
Lin Z; McDermott A; Shao L; Kannan A; Morgan M; Stack BC; Moreno M; Davis DA; Cornelius LA; Gao L
Cancer Lett; 2014 Mar; 344(2):272-281. PubMed ID: 24262658
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
13. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
15. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860
[TBL] [Abstract][Full Text] [Related]
17. Merkel cell carcinoma: more deaths but still no pathway to blame.
Lemos B; Nghiem P
J Invest Dermatol; 2007 Sep; 127(9):2100-3. PubMed ID: 17700621
[TBL] [Abstract][Full Text] [Related]
18. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
Ravi RK; Thiagalingam A; Weber E; McMahon M; Nelkin BD; Mabry M
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):543-9. PubMed ID: 10100985
[TBL] [Abstract][Full Text] [Related]
19. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
Karreth FA; DeNicola GM; Winter SP; Tuveson DA
Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
